Adverse reactions to oral antidiabetic agents.
D000092:Acetohexamide / Q000009:adverse effects; D000138:Acidosis / Q000139:chemically induced; D000284:Administration, Oral; D000740:Anemia / Q000139:chemically induced; D002747:Chlorpropamide / Q000009:adverse effects; D004336:Drug Antagonism; D004357:Drug Synergism; D004739:England; D000431:Ethanol; D005260:Female; D005333:Fetus / Q000187:drug effects; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D007328:Insulin / Q000009:adverse effects; D008687:Metformin / Q000009:adverse effects; D010629:Phenformin / Q000009:adverse effects; D011247:Pregnancy; D012606:Scotland; D012871:Skin Diseases / Q000139:chemically induced; D012877:Skin Manifestations; D014042:Tolazamide / Q000009:adverse effects; D014044:Tolbutamide / Q000009:adverse effects; D014852:Wales
D007004:Hypoglycemic Agents; D007328:Insulin; D000431:Ethanol; D008687:Metformin; D014044:Tolbutamide; D014042:Tolazamide; D010629:Phenformin; D000092:Acetohexamide; D002747:Chlorpropamide